The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the...

data.gov80

Biologics share of total drug costs in Canada by public drug plan 2021/2022

生物药品

药品费用与支出

Biologic share of total drug costs in select Canadian public drug plans in 2021/2022

Statista80

Evaluation of orphan maintained biological medicinal products in the European Union between 2018 to 2023: a regulatory perspective

孤儿药评价

生物药品

Orphan medicinal products (OMPs) authorized by the European Union (EU) benefit from market exclusivity, fee waivers, and national incentives. Maintaining orphan status during a marketing authorization

DataCite Commons2024-11-29 更新80